Abstract:As normal tissues contain normal tissue stem cells (NSCs), tumors are thought to contain tumor stem cells (TSCs) which perform self-renewal and generate their progenies. TSC can be a therapeutic target; however, cancer therapies targeting TSCs are limited, because most of the TSC markers are shared by NSCs. Therefore, it is important to identify TSC-specific markers. Previously, we reported that doublecortin-like kinase 1 (Dclk1)-positive epithelial cells do not produce any progenies in the normal small intestine but supply progeny tumor cells in the tumors of Apc mice. Selective ablation of Dclk1-positive TSCs collapses the intestinal tumors of Apc mice. Therefore, Dclk1 appears to be a specific marker of TSCs in the mouse intestinal tumors. In the present study, we performed microarray analysis in order to investigate the characteristics of Dclk1-positive TSCs in the tumors of Apc mice. Dclk1-positive tumor cells had higher expression levels of cyclooxygenase 1 (Cox1), leukotriene C4 synthase (Ltc4s), and arachidonate 5-lipoxygenase activating protein (Alox5ap) than Dclk1-negative cells in the tumors of Apc mice, suggesting that Dclk1positive cells in the tumors of Apc mice had higher expression levels of the genes which were related to prostaglandin and leukotriene metabolism. As well, microarray analysis revealed that gustducin alpha and gamma subunits, transient receptor potential cation channel, subfamily M, member 5 (TRPM5), and phospholipase C beta 2 were more highly expressed in Dclk1-positive tumor cells. Thus, Dclk1-positive tumor cells seemed to possess the characteristic of Tuft cells. Furthermore, Dclk1-positive tumor cells had higher expression level of Ras-related C3 botulinum toxin substrate 2 (Rac2) than Dclk1-negative tumor cells in Apc mouse intestine. In order to elucidate the role of Rac2 in Dclk1-positive TSCs, we generated tumor spheroids from Apc mouse tumors, and administrated EHT1864, Rac inhibitor to the spheroids. Following 5-day treatment with EHT1864, the growth of the tumor spheroids was significantly suppressed. Importantly, on day1, EHT1864 treatment significantly reduced the proportion of Dclk1-positive cells in the tumor spheroids. These results suggested that Rac2 played some roles for the maintenance of the intestinal tumor spheroids. In conclusion, this study may provide new insights into the maintenance mechanisms of Dclk1-positive TSC in the intestinal tumors, and give us hints to develop novel therapeutic strategies targeting TSCs against colorectal cancers.

TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium

Su2003 Nrip2, a Novel Regulator of the Non-Canonical Wnt Pathway, Promotes the Self-Renewal of Colorectal Cancer Initiating Cells

Su2005 DCLK1 Promotes Pancreatic Cancer Cell Clonogenicity and Invasiveness

mTOR is critical for intestinal T-cell homeostasis and resistance to Citrobacter rodentium

TSC 1 Regulates the Balance Between Effector and Regulatory T Cells

Nuclear factor of activated T-cells 5 increases intestinal goblet cell differentiation through an mTOR/Notch signaling pathway

Tsc1 regulates tight junction independent of mTORC1

Disruption of Shp2 Tyrosine Phosphatase Promotes Hes1/Stat3 Complex in Intestinal Epithelia, Contributing to Enhanced Self‐renewal Capacity and Impaired Differentiation in the Crypt Niche

Tuberous Sclerosis 1 (Tsc1)-Dependent Metabolic Checkpoint Controls Development of Dendritic Cells

Mammalian Target of Rapamycin Signaling Pathway Changes with Intestinal Epithelial Cells Renewal Along Crypt-Villus Axis

Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition

Gut Epithelial TSC1/mTOR Controls RIPK3-dependent Necroptosis in Intestinal Inflammation and Cancer.

mTORC2 acts as a gatekeeper for mTORC1 deficiency-mediated impairments in ILC3 development

TSC1 controls macrophage polarization to prevent inflammatory disease

The Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis in Intestinal Epithelial Cells Regulates Intestinal Barrier Function During Intestinal Epithelial Cells–CD4+T-Cell Interactions

TSC1-mTOR Signaling Determines the Differentiation of Islet Cells.

Modulation of TSC-mTOR Signaling on Immune Cells in Immunity and Autoimmunity.

InR and Pi3K maintain intestinal homeostasis through STAT/EGFR and Notch signaling in enteroblasts

Amino acid transporter SLC7A5 regulates cell proliferation and secretary cell differentiation and distribution in the mouse intestine

Tsc Tumour Suppressor Proteins Antagonize Amino-Acid–tor Signalling

Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models.